🔎 Trials Near Me

Beranda › Kanker Paru › Iowa › Cedar Rapids

Uji klinis Kanker Paru di Cedar Rapids, IA

14 studi untuk Kanker Paru mencari peserta di lokasi sekitar Cedar Rapids (dalam radius sekitar 30 mil). Buka studi untuk melihat kriteria peserta dan cara menghubungi tim studi.

Teks studi resmi (Bahasa Inggris)

Merekrut peserta untuk studi di sini? Tampilkan di bagian atas halaman ini — $99 selama 30 hari →

Testing the Addition of a Type of Drug Called Immunotherapy to the Usual Chemotherapy Treatment for Non-small Cell Lung Cancer, an ALCHEMIST Treatment Trial (Chemo-IO [ACCIO])

Menerima pesertaFase 3
  • Physicians' Clinic of Iowa PC, Cedar Rapids
  • Mercy Hospital, Cedar Rapids
  • Oncology Associates at Mercy Medical Center, Cedar Rapids
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 2 Okt 2026 · NCT04267848

Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection

Menerima pesertaStudi observasionalSukarelawan sehat diterima
  • Mercy Hospital, Cedar Rapids
  • Oncology Associates at Mercy Medical Center, Cedar Rapids
Usia 40 hingga 75 · Semua jenis kelamin · Diperbarui 2 Okt 2026 · NCT05334069

Chemotherapy Combined With Immunotherapy Versus Immunotherapy Alone for Older Adults With Stage IIIB-IV Lung Cancer, The ACHIEVE Trial

Menerima pesertaFase 3
  • Mercy Hospital, Cedar Rapids
  • Oncology Associates at Mercy Medical Center, Cedar Rapids
Usia 70 ke atas · Semua jenis kelamin · Diperbarui 1 Okt 2026 · NCT06096844

Study of Daraxonrasib (RMC-6236) in Patients With RAS Mutated NSCLC (RASolve 301)

Menerima pesertaFase 3
  • University of Iowa Hospitals & Clinics, Iowa City · 25 mi jauhnya
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 29 Sep 2026 · NCT06881784

A Study to Evaluate the Safety, Tolerability, Drug Levels, and Preliminary Efficacy of BMS-986507 Combinations in Adult Participants With Advanced Solid Tumors

Menerima pesertaFase 1/2
  • Local Institution - 0065, Iowa City · 25 mi jauhnya
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 23 Sep 2026 · NCT06618287

Safety, Efficacy, and Pharmacokinetics of BNT327 in Combination With Chemotherapy and Other Investigational Agents for Lung Cancer

Menerima pesertaFase 2/3
  • Physicians Clinic of Iowa, Cedar Rapids
  • Holden Comprehensive Cancer Center, University of Iowa Hospitals and Clinics, Iowa City · 25 mi jauhnya
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 22 Sep 2026 · NCT06712316

Safety and Efficacy of BNT327, an Investigational Therapy in Combination With Chemotherapy for Patients With Untreated Small-cell Lung Cancer

Menerima pesertaFase 3
  • Helen G. Nassif Community Cancer Center, Cedar Rapids
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 1 Sep 2026 · NCT06712355

Testing the Addition of High Dose, Targeted Radiation to the Usual Treatment for Locally-Advanced Inoperable Non-Small Cell Lung Cancer

Menerima pesertaFase 3
  • Saint Luke's Hospital, Cedar Rapids
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 17 Agu 2026 · NCT05624996

CHAMP Lung Cancer Screening Program

Menerima peserta
  • University of Iowa, Iowa City · 25 mi jauhnya
Usia 50 hingga 77 · Semua jenis kelamin · Diperbarui 16 Jun 2026 · NCT07572773

Study to Evaluate the Safety, Tolerability & Efficacy of TNG462 in Combination in PDAC & NSCLC Patients

Menerima pesertaFase 1/2
  • University of Iowa Health Care, Iowa City · 25 mi jauhnya
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 14 Mei 2026 · NCT06922591

Temozolomide and Atezolizumab for Subsequent Line for the Treatment of Metastatic or Recurrent Small Cell Lung Cancer

Menerima pesertaFase 2
  • University of Iowa Hospitals and Clinics, Iowa City · 25 mi jauhnya
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 8 Apr 2026 · NCT04919382

Using Xe MRI to Guide Radiation Therapy for Lung Cancer

Menerima pesertaFase 2
  • University of Iowa, Iowa City · 25 mi jauhnya
Usia 18 hingga 80 · Semua jenis kelamin · Diperbarui 2 Jan 2026 · NCT06925295

SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry

Menerima pesertaStudi observasional
  • Massive Bio SYNERGY-AI site, Iowa City · 25 mi jauhnya
Semua usia · Semua jenis kelamin · Diperbarui 28 Okt 2025 · NCT03452774

Uji klinis Kanker Paru di kota lain

Studi lain di Cedar Rapids

Dari ClinicalTrials.gov, data diambil 5 Okt 2026. Setiap studi menetapkan kriteria kelayakannya sendiri; tim studi yang menentukan siapa yang bisa bergabung.